Page last updated: 2024-12-05

methyl parathion

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Methyl Parathion: The methyl homolog of parathion. An effective, but highly toxic, organothiophosphate insecticide and cholinesterase inhibitor. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

parathion-methyl : A C-nitro compound that is 4-nitrophenol substituted by a (dimethoxyphosphorothioyl)oxy group at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID4130
CHEMBL ID346516
CHEBI ID38746
SCHEMBL ID75215
MeSH IDM0013616

Synonyms (202)

Synonym
phosphorothioic acid, o,o-dimethyl o-(4-nitrophenyl) ester
methyl parathion
DIVK1C_006444
KBIO1_001388
o,o-dimethyl o-(4-nitrophenyl) thiophosphate
metafos
parathion-methyl
methylparathion
298-00-0
SPECTRUM_001763
SPECTRUM5_001922
BSPBIO_002267
NCGC00091101-01
parathion-metile [italian]
methyl 1605
o,o-dimetil-o-(4-nitro-fenil)-monotiofosfato [italian]
oleovofotox
p-nitrophenyldimethylthionophosphate
cekumethion
metaphos
hsdb 1168
parathion methyl homolog
metron (pesticide)
metilparation (hungarian)
devithion
thiophenit
bladan-m
epa shaughnessy code: 053501
o,o-dimethyl-o-(4-nitrophenyl)-thionophosphat [german]
quinophos
drexel methyl parathion 4e
wofatox
rcra waste number p071
methyl fosferno
8056hc
folidol m 50
demethylfenitrothion
dimethyl p-nitrophenyl phosphorothionate
dimethyl-p-nitrophenyl thionphosphate
o,o-dimethyl o-(p-nitrophenyl) phosphorothioate
sinafid m-48
vofatox
methyl-e 605
folidol-80
thylpar m-50
kilex parathion
penncap-m
dalf
phosphorothioic acid, o,o-dimethyl o-(p-nitrophenyl) ester
einecs 206-050-1
fosferno m 50
rcra waste no. p071
parapest m-50
m-parathion
caswell no. 372
a-gro
folidol m
ent 17,292
o,o-dimethyl-o-p-nitrofenylester kyseliny thiofosforecne [czech]
ai3-17292
nci-c02971
phenol, p-nitro-, o-ester with o,o-dimethyl phosphorothioate
mepaton
o,o-dimethyl o-p-nitrophenyl thiophosphate
nitrox 80
paratox
dimethyl p-nitrophenyl thionophosphate
tekwaisa
yphos
methyl niran
penncap mls
dimethyl 4-nitrophenyl phosphorothionate
me 605
methylthiophos
azofos
meptox
partron m
m40 & 80
parton-m
me 605sp
wofatox 50 ec
folidol 600
nitrox
e 601
o,o-dimethyl-o-(4-nitro-phenyl)-monothiophosphat [german]
bay e-601
bladan m
folidol m-40
metylparation [czech]
o,o-dimethyl-o-(4-nitrophenyl) phosphorothioate
brn 1914724
bay 11405
me-parathion
o,o-dimethyl-o-(p-nitrophenyl)-thionophosphat [german]
o,o-dimethyl-o-(4-nitro-fenyl)-monothiofosfaat [dutch]
parathion methyl
metacide
ccris 405
dimethyl p-nitrophenyl monothiophosphate
parathion-methyl [bsi:iso]
o,o-dimethyl-o-p-nitrofenylthiofosfat [czech]
metyloparation [polish]
metafos (pesticide)
epa pesticide chemical code 053501
phenol, p-nitro-, o-ester with o,o-dimethylphosphorothioate
metacide (insecticide)
wofatox 80
paratuf
azophos
metacid 50
thiophosphate de o,o-dimethyle et de o-(4-nitrophenyle) [french]
parathion-methyl, analytical standard
dimethyl parathion
CHEBI:38746 ,
o,o-dimethyl o-(4-nitrophenyl) phosphorothioate
phosphorothioic acid, o,o-dimethyl-o-p-nitrophenyl ester
dimethyl p-nitrophenyl thiophosphate
o,o-dimethyl o-(p-nitrophenyl) thionophosphate
NCGC00091101-04
NCGC00091101-03
NCGC00091101-02
KBIO2_007379
KBIO2_004811
KBIOSS_002244
KBIO2_002243
KBIO3_001767
KBIOGR_000987
SPECPLUS_000348
SPECTRUM2_001849
SPBIO_001638
SPECTRUM3_000804
SPECTRUM4_000644
SPECTRUM330010
NCGC00091101-05
NCGC00091101-06
MLS002454415
smr000778017
CHEMBL346516
methyl parathione
metacid
NCGC00091101-08
NCGC00091101-07
cas-298-00-0
NCGC00254900-01
tox21_202303
dtxcid30855
dtxsid1020855 ,
NCGC00259852-01
tox21_300998
A820056
dimethoxy-(4-nitrophenoxy)-sulfanylidenephosphorane
dimethoxy-(4-nitrophenoxy)-sulfanylidene-$l^{5}-phosphane
CCG-39387
penncap m
o,o-dimethyl-o-(4-nitrophenyl)-thionophosphat
o,o-dimethyl-o-(p-nitrophenyl)-thionophosphat
o,o-dimethyl-o-p-nitrofenylthiofosfat
methyl parathion, solid
o,o-dimethyl-o-(4-nitro-phenyl)-monothiophosphat
methyl parathion, solid [na2783] [poison]
o,o-dimethyl-o-(4-nitro-fenyl)-monothiofosfaat
41bcl2o91d ,
parathion-metile
methyl parathion, liquid
unii-41bcl2o91d
4-06-00-01336 (beilstein handbook reference)
methyl parathion, liquid [na3018] [poison]
metylparation
o,o-dimethyl-o-p-nitrofenylester kyseliny thiofosforecne
o,o-dimetil-o-(4-nitro-fenil)-monotiofosfato
metyloparation
thiophosphate de o,o-dimethyle et de o-(4-nitrophenyle)
AKOS015897269
SCHEMBL75215
methyl parathion [iarc]
bay-11405
parathion-methyl [iso]
methyl parathion [mi]
bay e 601
parathion-methyl [hsdb]
W-106971
dimethyl 4-nitrophenyl phosphorothioate
ent 17292
methyl-parathion
parataf
o,o-dimethyl o-(p-nitrophenyl) thiophosphate
o,o-dimethyl o-4-nitrophenyl phosphorothioate
oms 213
wofotox
methyl-bladan
o,o-dimethyl o-(4-nitrophenyl) thiophosphate #
parathion-methyl, pestanal(r), analytical standard
parathion-methyl 10 microg/ml in cyclohexane
parathion-methyl 100 microg/ml in toluene
parathion-methyl 100 microg/ml in acetonitrile
Q421693
BCP09201
parathion-methyl 1000 microg/ml in acetone
dimethoxy-(4-nitrophenoxy)-sulfanylidene-lambda5-phosphane
o,o-dimethyl o-(4-nitrophenyl)phosphorothioate
parathion-methyl 100 microg/ml in acetone
methyl parathion solution

Research Excerpts

Overview

Methyl parathion (Me-Pa) is an extremely toxic organophosphorus pesticide still used in developing countries. It generates reactive oxygen species (ROS) through its biotransformation. Methyl parthion (MP) is a highly toxic organophile pesticide associated with water, soil, and air pollution events.

ExcerptReferenceRelevance
"Methyl parathion is an organophosphorus pesticide widely employed worldwide to control pests in agricultural and domestic environments. "( Proteomic analysis of Burkholderia zhejiangensis CEIB S4-3 during the methyl parathion degradation process.
Castrejón-Godínez, ML; Encarnación-Guevara, S; Hernández-Ortiz, M; Martínez-Batallar, ÁG; Mussali-Galante, P; Ortiz-Hernández, ML; Rodríguez, A; Sánchez-Salinas, E; Tovar-Sánchez, E, 2022
)
2.4
"Methyl parathion (Me-Pa) is an extremely toxic organophosphorus pesticide still used in developing countries. "( Methyl parathion causes genetic damage in sperm and disrupts the permeability of the blood-testis barrier by an oxidant mechanism in mice.
González-Mariscal, L; Martín-Tapia, D; Ortega-Olvera, JM; Piña-Guzmán, B; Quintanilla-Vega, B; Solís-Heredia, MJ; Tello-Mora, P; Urióstegui-Acosta, M, 2020
)
3.44
"Methyl parathion (MP) is a commonly used organophosphorus insecticide in commercial farming. "( Epigallocatechin-3-gallate (EGCG) protects the oocytes from methyl parathion-induced cytoplasmic deformities by suppressing oxidative and endoplasmic reticulum stress.
Adiga, SK; Crasta, DN; Gopalan, D; Hegde, S; Kalthur, G; Mutalik, S; Poojary, KK; Rasquinha, R; Siddiqui, S, 2020
)
2.24
"Methyl parathion (MP) is a highly toxic organophosphorus pesticide associated with water, soil, and air pollution events. "( Transcriptomic analysis of Burkholderia cenocepacia CEIB S5-2 during methyl parathion degradation.
Castrejón-Godínez, ML; Encarnación, S; Fernández-López, M; Gama-Martínez, Y; Mussali-Galante, P; Ortiz-Hernández, ML; Rodríguez, A; Salazar, E; Tovar-Sánchez, E, 2021
)
2.3
"Methyl parathion (MP) is a highly toxic organophosphate and its exposure may lead to substantial adverse effects to human health. "( Dual-opposite multi-walled carbon nanotube modified carbon fiber microelectrode for microfluidic chip-capillary electrophoresis determination of methyl parathion metabolites in human urine.
Du, F; Fung, YS, 2018
)
2.12
"Methyl parathion (Me-Pa) is an oxidizing organophosphate (OP) pesticide that generates reactive oxygen species (ROS) through its biotransformation. "( Epigenetic modulation of Nrf2 and Ogg1 gene expression in testicular germ cells by methyl parathion exposure.
Alvarado-Cruz, I; Hernandez-Cortes, D; Quintanilla-Vega, B; Solís-Heredia, MJ, 2018
)
2.15
"Methyl parathion (MP) is a widely used organophosphate pesticide, which has been associated to various toxic effects in organisms."( ABCB1 and ABCC4 efflux transporters are involved in methyl parathion detoxification in ZFL cells.
Almeida, DV; Batista, CR; Marins, LF; Nornberg, BF; Trindade, GS, 2015
)
1.39
"Methyl parathion (MP) is a high venenosus insecticide. "( Protective effect of sodium aescinate on lung injury induced by methyl parathion.
Du, Y; Fu, FH; Jiang, N; Li, C; Ren, RT; Wang, T; Zhao, DL, 2011
)
2.05
"Methyl parathion is an organophosphorus pesticide that has been widely used in the field of agriculture for insect pest control."( Immobilization of microbial cells on inner epidermis of onion bulb scale for biosensor application.
D'Souza, SF; Kumar, J, 2011
)
1.09
"Methyl parathion (MP) is a widely used organophosphorus pesticide, which has been related to a broad spectrum of toxic effects on environmental organisms. "( Differential expression profile of membrane proteins in zebrafish (Danio rerio) brain exposed to methyl parathion.
Huang, HQ; Huang, QY, 2011
)
2.03
"Methyl parathion (MP) is an extensively used organophosphorus pesticide, which has been associated with a wide spectrum of toxic effects on environmental organisms. "( Alterations of protein profile in zebrafish liver cells exposed to methyl parathion: a membrane proteomics approach.
Huang, HQ; Huang, Q, 2012
)
2.06
"Methyl parathion (MP) is a widely used organophosphorus pesticide that causes severe health and environmental effects. "( Alteration of the kidney membrane proteome of Mizuhopecten yessoensis induced by low-level methyl parathion exposure.
Huang, HQ; Huang, X, 2012
)
2.04
"Methyl parathion is an organophosphorus (OP) insecticide with insecticidal properties derived from acetylcholinesterase (AChE) inhibition; this same property is also the root of its toxicity in humans. "( Methyl parathion: a review of health effects.
Abou-Donia, MB; Abu-Qare, AW; Borton, AJ; Garcia, SJ; Meeker-O'Connell, WA,
)
3.02
"Methyl parathion (MP) is an organophosphate pesticide illegally applied to the interiors of many hundreds of homes throughout the United States by unlicensed pesticide applicators. "( Urinary p-nitrophenol as a biomarker of household exposure to methyl parathion.
Barr, D; Burton, A; Chen, E; Dimos, J; Hryhorczuk, DO; McCann, K; Moomey, M; Runkle, K; Saxer, T; Slightom, J, 2002
)
2
"Methyl parathion (MeP) is a very hazardous pesticide freely used in agriculture in Mexico. "( Methyl parathion toxicity to and removal efficiency by Typha latifolia in water and artificial sediments.
Amaya-Chávez, A; Galar-Martínez, M; López-López, E; Martínez-Tabche, L, 2006
)
3.22
"Methyl parathion (MP) is an organophosphorus insecticide used worldwide in agriculture and aquaculture due to its high activity against a broad spectrum of insect pests. "( Oxidative stress biomarkers in the freshwater characid fish, Brycon cephalus, exposed to organophosphorus insecticide Folisuper 600 (methyl parathion).
de Almeida, JA; Kalinin, AL; Monteiro, DA; Rantin, FT, 2006
)
1.98
"Methyl parathion (MP) is a well-known organophosphorus pesticide, to which humans are exposed in fruit and vegetables as residues of 0-2 mg/kg, children being at higher risk of exposure. "( Neonatal methyl parathion exposure affects the growth and functions of the male reproductive system in the adult rat.
Abhilash, K; Bairy, KL; Kumar, HH; Narayana, K; Nayanatara, A; Prashanthi, N, 2006
)
2.19
"Methyl parathion (MP) is an organophosphate pesticide used in agriculture, although quite often illegally used indoors to contain insects. "( An organophosphate insecticide methyl parathion (o- o- dimethyl o-4-nitrophenyl phosphorothioate) induces cytotoxic damage and tubular atrophy in the testis despite elevated testosterone level in the rat.
Bairy, LK; D'Souza, UJ; Narayana, K; Nayanatara, A; Prashanthi, N, 2006
)
2.06
"Methyl parathion (MP) is a pesticide widely used to protect crops but also illegally used in many countries for spraying homes and businesses to contain insects. "( The reproductive toxicity of the organophosphate pesticide 0, 0-dimethyl 0-4-nitrophenyl phosphorothioate (methyl parathion) in the male rat.
Bairy, KL; Chandra Kumar, HH; D'Souza, UJ; Narayana, K; Nayanatara, A; Prashanthi, N, 2006
)
1.99
"Methyl parathion is a widely used agricultural insecticide, and the recent unlicensed use of this compound in homes has led to the evacuation of approximately 1100 persons in Mississippi. "( Immunotoxicological assessment of methyl parathion in female B6C3F1 mice.
Carr, R; Crittenden, PL; Pruett, SB, 1998
)
2.02

Actions

ExcerptReferenceRelevance
"The methyl parathion-induced increase in LC neuronal activity returned to normal within 30 min while the blood acetylcholinesterase activity remained inhibited for over 1 h."( Methyl parathion increases neuronal activities in the rat locus coeruleus.
Ho, IK; Li, XR; Ma, T; Rockhold, RW; Zhou, W; Zhu, H,
)
2.05

Treatment

Methyl parathion treatment caused more damage in the plant cells of barley as compared to hexaconazole, which may be closely related to higher genotoxicity and oxidative stress. No change in the ovarian weight with -0.64% and -9.63% hypertrophy respectively.

ExcerptReferenceRelevance
"Methyl parathion treatment caused more damage in the plant cells of barley as compared to hexaconazole, which may be closely related to higher genotoxicity and oxidative stress."( Comparative analyses of genotoxicity, oxidative stress and antioxidative defence system under exposure of methyl parathion and hexaconazole in barley (Hordeum vulgare L.).
Dubey, P; Mishra, AK; Singh, AK, 2015
)
1.35
"Treatment with methyl parathion for 1 and 5 days revealed no change in the ovarian weight with -0.64% and -9.63% hypertrophy respectively and no change in healthy and atretic follicles when compared with hemicastrated oil-treated controls."( Temporal effect of methyl parathion on ovarian compensatory hypertrophy, follicular dynamics and estrous cycle in hemicastrated albino rats.
Asmathbanu, I; Kaliwal, BB, 1997
)
0.97

Toxicity

Mouse livers perfused in situ with the pesticide methyl parathion (O,O-dimethyl O-P-nitrophenyl phosphorothioate) resulted in the appearance of the toxic metabolite, methyl paraoxon. The toxic signs of hypercholinergic (anticholinesterase) activity with maximal severity, including muscle fasciculations and convulsions within 15 to 30 min, persisting for about 2 hr.

ExcerptReferenceRelevance
" Prenatal toxic action of the pesticides used today may be detrimental to human and animal health."( [Studies on the prenatally toxic effect of parathionemethyl in Wistar rats compared to cyclophosphamide and trypan blue].
Fuchs, V; Golbs, S; Kühnert, M; Osswald, F, 1976
)
0.26
"375 mg/kg body weight, equivalent to 1/2 LD50, 1/4 LD50, 1/8 LD50 and 1/16 LD50, administered to female mice, elicited positive responses in bone marrow and peripheral blood micronuclei tests."( In vivo genotoxic effects in mice of Metacid 50, an organophosphorus insecticide.
Mathew, G; Rahiman, MA; Vijayalaxmi, KK, 1990
)
0.28
" dose of 5 mg/kg methyl parathion, showed the toxic signs of hypercholinergic (anticholinesterase) activity with maximal severity, including muscle fasciculations and convulsions within 15 to 30 min, persisting for about 2 hr."( Methyl parathion acute toxicity: prophylaxis and therapy with memantine and atropine.
Gupta, RC; Kadel, WL,
)
1.91
"Mouse livers perfused in situ with the pesticide methyl parathion (O,O-dimethyl O-P-nitrophenyl phosphorothioate) resulted in the appearance of the toxic metabolite, methyl paraoxon (O,O-dimethyl-O-P-nitrophenyl phosphate), in the effluent perfusate."( The role of the liver in mediating the acute toxicity of the pesticide methyl parathion in the mouse.
Sultatos, LG,
)
0.62
" Larvae 24 h, 48 h and 72 h old, heterozygous for various recessive genetic markers on the first and third chromosomes, were exposed to the LD50 and half of this dose for different periods of time."( Genotoxicity of metacid established through the somatic and germ line mosaic assays and the sex-linked recessive lethal test in Drosophila.
Das, CC; Dey, L; Majhi, B; Tripathy, NK, 1987
)
0.27
" Normal laboratory light conditions had no effect on the mutagenicity tests, however, exposure of methyl parathion in the petri dish containing the tester strain TA100 and rat liver microsomal and cytosolic enzymes reduced the mutagenic activity and increased the toxic effects of methyl parathion."( Genotoxicity of methyl parathion in short-term bacterial test systems.
Mumma, RO; Rashid, KA, 1984
)
0.83
" Effects of both substances on immunological variables were detectable at the 1/75 LD50 dose level, but different parameters were affected in the three consecutive generations."( Immunotoxicity study of repeated small doses of dimethoate and methylparathion administered to rats over three generations.
Dési, I; Institóris, L; Siroki, O, 1995
)
0.29
"Detectability of toxic effects by repeated doses of dimethoate (DM) and methylparathion (MPT) were investigated by geno-and immunotoxicological methods in male Wistar rats following a 28-day oral exposure."( Simultaneous geno- and immunotoxicological investigations for early detection of organophosphate toxicity in rats.
Dési, I; Institóris, L; Nehéz, M; Siroki, O; Undeger, U, 2000
)
0.31
" Safe levels were calculated for short-term (0."( Short-term and long-term survival studies in Rana tigrina tadpoles with reference to methyl parathion toxicity.
Kennedy, IJ; Sampath, K, 2001
)
0.53
" Four common environmental contaminants (atrazine, methyl parathion, pentachlorophenol (PCP), and phenanthrene) were used as model compounds, representing different physico-chemical properties and toxic modes of action."( Toxicity and bioaccumulation of xenobiotic organic compounds in the presence of aqueous suspensions of aggregates of nano-C(60).
Baun, A; Hartmann, NB; Koch, CB; Rasmussen, RF; Sørensen, SN, 2008
)
0.6
" Many recently published studies have indicated that human exposure to OPI may be associated with neurologic, hematopoietic, cardiovascular, and reproductive adverse effects."( Involvement of oxidative stress in methyl parathion and parathion-induced toxicity and genotoxicity to human liver carcinoma (HepG₂) cells.
Edwards, FL; Tchounwou, PB; Yedjou, CG, 2013
)
0.67
" Cd was the most toxic chemical (LC50 = 14."( Toxicity of cadmium, lead, mercury and methyl parathion on Euchlanis dilatata Ehrenberg 1832 (Rotifera: Monogononta).
Arias-Almeida, JC; Rico-Martínez, R, 2011
)
0.64
" carinata was sensitive to both MP and PNP; however, the parent compound was more toxic than its metabolite."( Acute toxicity of the insecticide methyl parathion and its hydrolytic product p-nitrophenol to the native Australian cladoceran Daphnia carinata.
Cáceres, T; Megharaj, M; Venkateswarlu, K, 2019
)
0.79
" For MP treatment, people have found that oxidative degradation of MP may generate some intermediates which are more toxic than MP itself, such as methyl paraoxon."( Study of detoxification of methyl parathion by dielectric barrier discharge (DBD) non-thermal plasma at gas-liquid interface:mechanism and bio-toxicity evaluation.
Fang, C; Huang, Q; Liu, C; Shao, C; Wang, S; Wu, Y, 2022
)
1.02

Pharmacokinetics

Methyl parathion disappeared monoexponentially from plasma and tissues. The half-life of methyl parathions was 51 minutes, its volume of distribution was 10.

ExcerptReferenceRelevance
" Pharmacokinetic studies showed that methyl parathion disappeared monoexponentially from plasma and tissues."( Placental transfer and pharmacokinetics of a single dermal dose of [14C]methyl parathion in rats.
Abdel-Rahman, AA; Abou-Donia, MB; Abu-Qare, AW; Kishk, AM, 2000
)
0.81
" Thus, studies were performed using adult female rats to define the pharmacokinetic parameters for methyl parathion after intravenous injection and to apply the described model to an examination of its pharmacokinetics after single oral or dermal exposure."( Pharmacokinetics of methyl parathion: a comparison following single intravenous, oral or dermal administration.
Baker, RC; Kramer, RE; Rockhold, RW; Wellman, SE,
)
0.67
" The half-life of methyl parathion was 51 minutes, its volume of distribution was 10."( Pharmacokinetics and pharmacodynamics of methyl parathion.
Ho, IK; Kramer, RE, 2002
)
0.91
" This study describes a physiologically based pharmacokinetic (PBPK) model developed to simulate the absorption of organophosphate pesticides, such as parathion, fenthion, and methyl parathion through porcine skin with flow-through cells."( A physiologically based pharmacokinetic model of organophosphate dermal absorption.
Baynes, RE; Brooks, JD; Gehring, R; Monteiro-Riviere, NA; Riviere, JE; van der Merwe, D, 2006
)
0.53

Compound-Compound Interactions

ExcerptReferenceRelevance
" In this study, SERS was combined with dispersive liquid-liquid microextraction (DLLME) to develop a rapid and reliable method for the detection of organophosphorus pesticides (OPPs)."( Rapid and reliable detection and quantification of organophosphorus pesticides using SERS combined with dispersive liquid-liquid microextraction.
Li, G; Li, X; Sun, Y; Wang, L; Wang, P; Xu, Y, 2022
)
0.72

Bioavailability

ExcerptReferenceRelevance
" For both substances a low bioavailability after oral administration was found."( Toxicokinetics of methyl parathion and parathion in the dog after intravenous and oral administration.
Audenaert, F; Belpaire, FM; Bogaert, MG; Braeckman, RA; Willems, JL, 1983
)
0.6
"24 h(-1), and its oral bioavailability was approximately 20%."( Pharmacokinetics of methyl parathion: a comparison following single intravenous, oral or dermal administration.
Baker, RC; Kramer, RE; Rockhold, RW; Wellman, SE,
)
0.45
" Despite a high absorption coefficient, oral bioavailability of methyl parathion was less than 5%, and concentrations in blood were 2% or less of those after intravenous exposure."( Pharmacokinetics and pharmacodynamics of methyl parathion.
Ho, IK; Kramer, RE, 2002
)
0.82
" Absorption was predicted to last for 30 hours and the bioavailability appeared to be very low."( Human methyl parathion poisoning.
Abeyewardene, M; Eddleston, M; Friberg, LE; Hodge, M; Isbister, GK; Mills, K; O'Connor, E; Patel, R, 2007
)
0.82
"Organophosphates insecticides (OPs) are one of the major environmental pollutants and their interaction with human serum albumin (HSA) has been shown to have significant effects on their bioavailability which is related to toxicokinetics and toxicodynamics in human body."( Mechanism of interactions between organophosphorus insecticides and human serum albumin: Solid-phase microextraction, thermodynamics and computational approach.
Bojko, B; Liu, F; Pawliszyn, J; Peng, W; Wang, X; Zhao, H, 2020
)
0.56
" To protect the public's health, screening these pollutants on-site and determining their soil bioavailability is important, but doing so is still challenging."( On-site screening method for bioavailability assessment of the organophosphorus pesticide, methyl parathion, and its primary metabolite in soils by paper strip biosensor.
Li, M; Li, Y; Lu, C; Ma, Z, 2023
)
1.13

Dosage Studied

Methyl parathion inhibited maternal and fetal brain AChE activity at 48 h and 24 h after dosing.

ExcerptRelevanceReference
" With T alone, rats of the postnatal group were dosed daily with 6 mg/kg for 21 days, while in the perinatal study females received 6 mg/kg daily from Day 7 of pregnancy until parturition."( Behavioral effects of methyl parathion and toxaphene exposure in rats.
Crowder, LA; Lanzaro, GC; Whitson, RS, 1980
)
0.58
" Treatment of the first generation (G1) with these doses began in animals 4 weeks of age; the parental males were dosed until separation of females, and after mating the females were treated until separation of their G2 offspring (at the age of 4 weeks), and the G3 generation was produced in the same way from treated parental G2 animals."( Immunotoxicity study of repeated small doses of dimethoate and methylparathion administered to rats over three generations.
Dési, I; Institóris, L; Siroki, O, 1995
)
0.29
" Repeated CPF exposures were associated with relatively similar degrees of ChE inhibition between the age groups during dosing but more extensive inhibition was noted in adults after termination of exposures."( Comparative neurochemical effects of repeated methyl parathion or chlorpyrifos exposures in neonatal and adult rats.
Liu, J; Olivier, K; Pope, CN, 1999
)
0.56
" Following application of methyl parathion, peak inhibition of maternal and fetal brain AChE activity occurred at 48 h and 24 h after dosing (17% and 48% of control activity, respectively)."( Inhibition of cholinesterase enzymes following a single dermal dose of chlorpyrifos and methyl parathion, alone and in combination, in pregnant rats.
Abdel-Rahman, A; Abou-Donia, MB; Abu-Qare, AW; Brownie, C; Kishk, AM, 2001
)
0.83
" The lesser effects on surface mAChR may explain why more severe signs appeared after each treatment with the high dosage of MPS than were observed previously with CPS, indicating little or no tolerance had developed to MPS."( The effects of repeated oral exposures to methyl parathion on rat brain cholinesterase and muscarinic receptors during postnatal development.
Carr, RL; Chambers, JE; Tang, J, 2003
)
0.58
" Oral LD1 values were estimated by dose-response studies (CPF = 80 mg/kg; MPS = 4 mg/kg, in peanut oil, 1 ml/kg)."( Interactive toxicity of the organophosphorus insecticides chlorpyrifos and methyl parathion in adult rats.
Karanth, S; Liu, J; Olivier, K; Pope, C, 2004
)
0.55
" Bethanecol dosing increased inspiratory respiratory resistance (cm H2O/L/min; p < ."( Physiologic implications of helium as a carrier gas for inhaled nitric oxide in a neonatal model of Bethanecol-induced bronchoconstriction.
Greenspan, JS; Miller, TL; Shaffer, TH; Sherman, TI; Singhaus, CJ, 2006
)
0.33
"To study dose-response relationship effects of mixed cypermethrin and methyl parathion on reproductive hormones, thyroid hormones, and immune functions in rats."( [Effects of mixed cypermethrin and methylparathion on endocrine hormone levels and immune functions in rats: I. Dose-response relationship].
Liu, P; Song, XX; Wen, WH; Yuan, WH, 2006
)
0.57
" Animals were orally gavaged using an incremental dosing regimen from postnatal day 1 (PND1) until PND8 with a low, medium, and high dosage for both CPS and MPS."( Altered muscarinic acetylcholine receptor subtype binding in neonatal rat brain following exposure to chlorpyrifos or methyl parathion.
Carr, RL; Chambers, JE; Guo-Ross, SX; Meek, EC, 2007
)
0.55
" The dosage of the two pesticides were (0, 1/300, 1/95 and 1/30) LD50, respectively."( [Studies on DNA damage of the neuron cell in rat offspring induced by cypermerthrin and methylparathrion during embryo exposure].
Liu, P; Wang, F; Wang, J; Wu, X, 2007
)
0.34
" GST activity significantly elevated in all the tissues except for in the liver treated with 38 mM dosage but did not change with 19 mM."( Subacute effects of methyl parathion on antioxidant defense systems and lipid peroxidation in rats.
Celik, I; Suzek, H, 2008
)
0.67
"05); a dose-response effect was not detected."( Decrease of muscarinic cholinergic receptors expression in placenta from rats exposed to methyl parathion.
González-García, B; González-Horta, C; Levario-Carrillo, M; Olave, ME; Ramos-Martínez, E; Sánchez-Ramírez, B, 2008
)
0.57
" Other than decreased body weight in the higher dosage groups, no effects on physical or reflex development were observed."( Developmental chlorpyrifos and methyl parathion exposure alters radial-arm maze performance in juvenile and adult rats.
Carr, RL; Chambers, JE; Givaruangsawat, S; Johnson, FO; Nail, CA, 2009
)
0.64
"2 mg/ml) of the gulonic acid lactone-methanol solution, and the concentrations (500 ng/ml) of organic phosphorus pesticide are same, to determine the best dosage of gulonic acid lactone."( [Research the role of gulonic acid lactone in the five kinds of organic phosphorus pesticide detection].
Du, H; Pan, X; Shao, H; Yan, H, 2010
)
0.36
"The OP hydrolase OpdA exhibits pharmacokinetics suitable for repeated dosing and increases short-term survival after severe methyl-parathion poisoning."( Kinetics and efficacy of an organophosphorus hydrolase in a rodent model of methyl-parathion poisoning.
Bird, SB; Gaspari, RJ; Gresham, C; Jackson, CJ; Rosenbaum, C, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (7)

RoleDescription
EC 3.1.1.7 (acetylcholinesterase) inhibitorAn EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of enzyme acetylcholinesterase (EC 3.1.1.7), which helps breaking down of acetylcholine into choline and acetic acid.
EC 3.1.1.8 (cholinesterase) inhibitorAn EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of cholinesterase (EC 3.1.1.8).
acaricideA substance used to destroy pests of the subclass Acari (mites and ticks).
agrochemicalAn agrochemical is a substance that is used in agriculture or horticulture.
genotoxinA role played by a chemical compound to induce direct or indirect DNA damage. Such damage can potentially lead to the formation of a malignant tumour, but DNA damage does not lead inevitably to the creation of cancerous cells.
environmental contaminantAny minor or unwanted substance introduced into the environment that can have undesired effects.
antifungal agentAn antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
organic thiophosphate
organothiophosphate insecticide
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
methyl parathion degradation15

Protein Targets (52)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HADH2 proteinHomo sapiens (human)Potency19.95260.025120.237639.8107AID886
Chain B, HADH2 proteinHomo sapiens (human)Potency19.95260.025120.237639.8107AID886
Chain A, Ferritin light chainEquus caballus (horse)Potency14.12545.623417.292931.6228AID485281
LuciferasePhotinus pyralis (common eastern firefly)Potency40.80350.007215.758889.3584AID1224835
acetylcholinesteraseHomo sapiens (human)Potency35.20570.002541.796015,848.9004AID1347395; AID1347398
USP1 protein, partialHomo sapiens (human)Potency56.23410.031637.5844354.8130AID504865
TDP1 proteinHomo sapiens (human)Potency4.35710.000811.382244.6684AID686978; AID686979
AR proteinHomo sapiens (human)Potency16.88110.000221.22318,912.5098AID1259243; AID1259247; AID588515; AID743036; AID743063
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency22.53580.011212.4002100.0000AID1030
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency1.93510.000657.913322,387.1992AID1259377
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency38.58090.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency24.33650.000417.946075.1148AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency1.12200.000214.376460.0339AID588532
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency34.77550.001530.607315,848.9004AID1224841; AID1224842; AID1259401
estrogen nuclear receptor alphaHomo sapiens (human)Potency41.83370.000229.305416,493.5996AID743069; AID743075; AID743079
67.9K proteinVaccinia virusPotency0.44970.00018.4406100.0000AID720579; AID720580
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency33.76520.001019.414170.9645AID588537; AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency21.90990.023723.228263.5986AID743223
aryl hydrocarbon receptorHomo sapiens (human)Potency47.75340.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency34.37620.001723.839378.1014AID743083
activating transcription factor 6Homo sapiens (human)Potency34.66540.143427.612159.8106AID1159516
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency24.541219.739145.978464.9432AID1159509
cellular tumor antigen p53 isoform aHomo sapiens (human)Potency28.37090.316212.443531.6228AID902; AID924
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency15.84890.354828.065989.1251AID504847
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency21.29420.010039.53711,122.0200AID1469; AID1567; AID1568; AID1570; AID1573
heat shock protein beta-1Homo sapiens (human)Potency12.29980.042027.378961.6448AID743210
mitogen-activated protein kinase 1Homo sapiens (human)Potency39.81070.039816.784239.8107AID995
nuclear factor NF-kappa-B p105 subunit isoform 1Homo sapiens (human)Potency8.91254.466824.832944.6684AID651749
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency10.61010.00798.23321,122.0200AID2546; AID2551
survival motor neuron protein isoform dHomo sapiens (human)Potency35.48130.125912.234435.4813AID1458
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency3.98110.031610.279239.8107AID884; AID885
lamin isoform A-delta10Homo sapiens (human)Potency3.54810.891312.067628.1838AID1487
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency3.98111.000012.224831.6228AID885
Cellular tumor antigen p53Homo sapiens (human)Potency61.13060.002319.595674.0614AID651631
Integrin beta-3Homo sapiens (human)Potency31.62280.316211.415731.6228AID924
Integrin alpha-IIbHomo sapiens (human)Potency31.62280.316211.415731.6228AID924
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency3.98111.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency3.98111.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency3.98111.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency3.98111.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency3.98111.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency3.98111.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency3.98111.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency3.98111.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency3.98111.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency3.98111.000012.224831.6228AID885
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)Potency31.62280.794312.269331.6228AID1568
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency3.98111.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency3.98111.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency3.98111.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency3.98111.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency3.98111.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (191)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
negative regulation of low-density lipoprotein receptor activityIntegrin beta-3Homo sapiens (human)
positive regulation of protein phosphorylationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
cell-substrate junction assemblyIntegrin beta-3Homo sapiens (human)
cell adhesionIntegrin beta-3Homo sapiens (human)
cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
integrin-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
embryo implantationIntegrin beta-3Homo sapiens (human)
blood coagulationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of gene expressionIntegrin beta-3Homo sapiens (human)
negative regulation of macrophage derived foam cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast migrationIntegrin beta-3Homo sapiens (human)
negative regulation of lipid storageIntegrin beta-3Homo sapiens (human)
response to activityIntegrin beta-3Homo sapiens (human)
smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
platelet activationIntegrin beta-3Homo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
cell-substrate adhesionIntegrin beta-3Homo sapiens (human)
activation of protein kinase activityIntegrin beta-3Homo sapiens (human)
negative regulation of lipid transportIntegrin beta-3Homo sapiens (human)
regulation of protein localizationIntegrin beta-3Homo sapiens (human)
regulation of actin cytoskeleton organizationIntegrin beta-3Homo sapiens (human)
cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of osteoblast proliferationIntegrin beta-3Homo sapiens (human)
heterotypic cell-cell adhesionIntegrin beta-3Homo sapiens (human)
substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
tube developmentIntegrin beta-3Homo sapiens (human)
wound healing, spreading of epidermal cellsIntegrin beta-3Homo sapiens (human)
cellular response to platelet-derived growth factor stimulusIntegrin beta-3Homo sapiens (human)
apolipoprotein A-I-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
wound healingIntegrin beta-3Homo sapiens (human)
apoptotic cell clearanceIntegrin beta-3Homo sapiens (human)
regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
positive regulation of angiogenesisIntegrin beta-3Homo sapiens (human)
positive regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
symbiont entry into host cellIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast proliferationIntegrin beta-3Homo sapiens (human)
mesodermal cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationIntegrin beta-3Homo sapiens (human)
negative regulation of lipoprotein metabolic processIntegrin beta-3Homo sapiens (human)
negative chemotaxisIntegrin beta-3Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosolIntegrin beta-3Homo sapiens (human)
regulation of serotonin uptakeIntegrin beta-3Homo sapiens (human)
angiogenesis involved in wound healingIntegrin beta-3Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeIntegrin beta-3Homo sapiens (human)
platelet aggregationIntegrin beta-3Homo sapiens (human)
cellular response to mechanical stimulusIntegrin beta-3Homo sapiens (human)
cellular response to xenobiotic stimulusIntegrin beta-3Homo sapiens (human)
positive regulation of glomerular mesangial cell proliferationIntegrin beta-3Homo sapiens (human)
blood coagulation, fibrin clot formationIntegrin beta-3Homo sapiens (human)
maintenance of postsynaptic specialization structureIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor internalizationIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor diffusion trappingIntegrin beta-3Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
regulation of trophoblast cell migrationIntegrin beta-3Homo sapiens (human)
regulation of extracellular matrix organizationIntegrin beta-3Homo sapiens (human)
cellular response to insulin-like growth factor stimulusIntegrin beta-3Homo sapiens (human)
negative regulation of endothelial cell apoptotic processIntegrin beta-3Homo sapiens (human)
positive regulation of T cell migrationIntegrin beta-3Homo sapiens (human)
cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of leukocyte migrationIntegrin alpha-IIbHomo sapiens (human)
cell-matrix adhesionIntegrin alpha-IIbHomo sapiens (human)
integrin-mediated signaling pathwayIntegrin alpha-IIbHomo sapiens (human)
angiogenesisIntegrin alpha-IIbHomo sapiens (human)
cell-cell adhesionIntegrin alpha-IIbHomo sapiens (human)
cell adhesion mediated by integrinIntegrin alpha-IIbHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (51)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
fibroblast growth factor bindingIntegrin beta-3Homo sapiens (human)
C-X3-C chemokine bindingIntegrin beta-3Homo sapiens (human)
insulin-like growth factor I bindingIntegrin beta-3Homo sapiens (human)
neuregulin bindingIntegrin beta-3Homo sapiens (human)
virus receptor activityIntegrin beta-3Homo sapiens (human)
fibronectin bindingIntegrin beta-3Homo sapiens (human)
protease bindingIntegrin beta-3Homo sapiens (human)
protein disulfide isomerase activityIntegrin beta-3Homo sapiens (human)
protein kinase C bindingIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor bindingIntegrin beta-3Homo sapiens (human)
integrin bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin beta-3Homo sapiens (human)
coreceptor activityIntegrin beta-3Homo sapiens (human)
enzyme bindingIntegrin beta-3Homo sapiens (human)
identical protein bindingIntegrin beta-3Homo sapiens (human)
vascular endothelial growth factor receptor 2 bindingIntegrin beta-3Homo sapiens (human)
metal ion bindingIntegrin beta-3Homo sapiens (human)
cell adhesion molecule bindingIntegrin beta-3Homo sapiens (human)
extracellular matrix bindingIntegrin beta-3Homo sapiens (human)
fibrinogen bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin alpha-IIbHomo sapiens (human)
identical protein bindingIntegrin alpha-IIbHomo sapiens (human)
metal ion bindingIntegrin alpha-IIbHomo sapiens (human)
extracellular matrix bindingIntegrin alpha-IIbHomo sapiens (human)
molecular adaptor activityIntegrin alpha-IIbHomo sapiens (human)
fibrinogen bindingIntegrin alpha-IIbHomo sapiens (human)
integrin bindingIntegrin alpha-IIbHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (47)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
glutamatergic synapseIntegrin beta-3Homo sapiens (human)
nucleusIntegrin beta-3Homo sapiens (human)
nucleoplasmIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin beta-3Homo sapiens (human)
cell-cell junctionIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
external side of plasma membraneIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
apical plasma membraneIntegrin beta-3Homo sapiens (human)
platelet alpha granule membraneIntegrin beta-3Homo sapiens (human)
lamellipodium membraneIntegrin beta-3Homo sapiens (human)
filopodium membraneIntegrin beta-3Homo sapiens (human)
microvillus membraneIntegrin beta-3Homo sapiens (human)
ruffle membraneIntegrin beta-3Homo sapiens (human)
integrin alphav-beta3 complexIntegrin beta-3Homo sapiens (human)
melanosomeIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
postsynaptic membraneIntegrin beta-3Homo sapiens (human)
extracellular exosomeIntegrin beta-3Homo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin beta-3Homo sapiens (human)
glycinergic synapseIntegrin beta-3Homo sapiens (human)
integrin complexIntegrin beta-3Homo sapiens (human)
protein-containing complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-PKCalpha complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-IGF-1-IGF1R complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-HMGB1 complexIntegrin beta-3Homo sapiens (human)
receptor complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-vitronectin complexIntegrin beta-3Homo sapiens (human)
alpha9-beta1 integrin-ADAM8 complexIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin alpha-IIbHomo sapiens (human)
focal adhesionIntegrin alpha-IIbHomo sapiens (human)
cell surfaceIntegrin alpha-IIbHomo sapiens (human)
platelet alpha granule membraneIntegrin alpha-IIbHomo sapiens (human)
extracellular exosomeIntegrin alpha-IIbHomo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin alpha-IIbHomo sapiens (human)
blood microparticleIntegrin alpha-IIbHomo sapiens (human)
integrin complexIntegrin alpha-IIbHomo sapiens (human)
external side of plasma membraneIntegrin alpha-IIbHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID1101168Resistance index, ratio of LC50 for organophosphate-resistant clone of Schizaphis graminum OR2 adult or last-instar nymphs to LC50 for organophosphate-susceptible clone of Schizaphis graminum OSS adult or last-instar nymphs2000Journal of agricultural and food chemistry, Oct, Volume: 48, Issue:10
Comparative toxicity of selected organophosphate insecticides against resistant and susceptible clones of the greenbug, Schizaphis graminum (Homoptera: aphididae).
AID1101171Insecticidal activity against organophosphate-resistant clone of Schizaphis graminum OR1 adult or last-instar nymphs assessed as insect mortality after 8 hr2000Journal of agricultural and food chemistry, Oct, Volume: 48, Issue:10
Comparative toxicity of selected organophosphate insecticides against resistant and susceptible clones of the greenbug, Schizaphis graminum (Homoptera: aphididae).
AID23272Partition coefficient (logP)1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Phosphorus analogues of gamma-aminobutyric acid, a new class of anticonvulsants.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1101170Insecticidal activity against organophosphate-resistant clone of Schizaphis graminum OR2 adult or last-instar nymphs assessed as insect mortality after 8 hr2000Journal of agricultural and food chemistry, Oct, Volume: 48, Issue:10
Comparative toxicity of selected organophosphate insecticides against resistant and susceptible clones of the greenbug, Schizaphis graminum (Homoptera: aphididae).
AID1101172Insecticidal activity against organophosphate-susceptible clone of Schizaphis graminum OSS adult or last-instar nymphs assessed as insect mortality after 8 hr2000Journal of agricultural and food chemistry, Oct, Volume: 48, Issue:10
Comparative toxicity of selected organophosphate insecticides against resistant and susceptible clones of the greenbug, Schizaphis graminum (Homoptera: aphididae).
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1101169Resistance index, ratio of LC50 for organophosphate-resistant clone of Schizaphis graminum OR1 adult or last-instar nymphs to LC50 for organophosphate-susceptible clone of Schizaphis graminum OSS adult or last-instar nymphs2000Journal of agricultural and food chemistry, Oct, Volume: 48, Issue:10
Comparative toxicity of selected organophosphate insecticides against resistant and susceptible clones of the greenbug, Schizaphis graminum (Homoptera: aphididae).
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (878)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990193 (21.98)18.7374
1990's144 (16.40)18.2507
2000's272 (30.98)29.6817
2010's225 (25.63)24.3611
2020's44 (5.01)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.08 (24.57)
Research Supply Index6.90 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index78.22 (26.88)
Search Engine Supply Index2.04 (0.95)

This Compound (47.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials17 (1.75%)5.53%
Reviews15 (1.54%)6.00%
Case Studies19 (1.95%)4.05%
Observational2 (0.21%)0.25%
Other919 (94.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]